Illumina (ILMN) Tops Q3 EPS by 32c, Offers Guidance
Get Alerts ILMN Hot Sheet
Price: $213.88 -1.99%
Revenue Growth %: +6.5%
Financial Fact:
Net income: 128.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.5%
Financial Fact:
Net income: 128.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Illumina (NASDAQ: ILMN) reported Q3 EPS of $1.45, $0.32 better than the analyst estimate of $1.13. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Illumina sees FY2021 EPS of $5.50-$5.60, may not compare versus the consensus of $5.73.
- For fiscal 2021, the company now expects both consolidated and Core Illumina revenue growth of approximately 36%. The company now expects GAAP earnings per diluted share of $4.41 to $4.51, and non-GAAP earnings per diluted share of $5.50 to $5.60, which includes dilution from GRAIL non-GAAP operating loss of approximately $1.00 and incremental dilution from the 9.8 million shares issued to fund the GRAIL acquisition of $0.15
For earnings history and earnings-related data on Illumina (ILMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- Premarket movers: Energy stocks rise on Iran tensions, Eaton jumps on UBS upgrade
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share